Characteristics of Health Care Workers with SARS-CoV-2 at a COVID-19 Hospital in Türkiye: Homologous Versus Heterologous Vaccination

Overview

Journal Pak J Med Sci

Specialty General Medicine

Date 2024 Sep 16

PMID 39281253

Authors

Isil Deniz Aliravci

Yusuf Haydar Ertekin

Gamze Can

Sevil Alkan

Affiliations

Soon will be listed here.

Abstract

Objective: Given the limited studies on types of vaccination and infection rates among health care workers (HCWs) in Türkiye, we analyzed the demographic, clinical, and vaccination characteristics as well as the attitudes of HCWs who have been infected with COVID-19.

Methods: We retrospectively analyzed demographic and clinical data on breakthrough COVID-19 infections in HCWs from hospital surveillance data collected between April 5, 2020, and November 1, 2022. The comparison was based on four subgroups that consisted of unvaccinated, one-shot-vaccinated, homologous vaccinated, and heterologous vaccinated individuals. Participants who received various combinations of Sinovac/CoronaVac and/or BioNTech/Pfizer vaccines were compared for detection of COVID-19.

Results: During a 33-month period of 744 HCWs who contracted COVID-19, women (65.3%) and nurses (28.9%) were the most affected, followed by doctors (25.8%). Of the infected HCWs, only 1.3% required hospitalization, 0.3% required ICU support, and 98.4% were outpatients. By vaccination status, 143 of the HCWs (19.2%) were unvaccinated, 292 (39.2%) were homologously vaccinated, 294 (39.5%) were heterologously vaccinated, 15 (2%) received a single shot, 206 (27.7%) received two shots, and 165 (22.2%) received three shots. All HCWs contracted COVID-19 at a mean of 134-days (range:1-539) after vaccination. While the proportions of homologously and heterologously vaccinated HCWs were similar, the time elapsed from vaccination to contracting COVID-19 varied (mean 143.4±106.7 vs.126.4±82.43 days).

Conclusions: Among both outpatients and inpatients with COVID-19, women HCWs outnumbered men HCWs. HCWs who received homologous vaccination contracted COVID-19 later than those who received heterologous vaccination.

References

Palacios R, Patino E, Piorelli R, Conde M, Batista A, Zeng G . Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary.... Trials. 2020; 21(1):853. PMC: 7558252. DOI: 10.1186/s13063-020-04775-4. View

Sahu A, Amrithanand V, Mathew R, Aggarwal P, Nayer J, Bhoi S . COVID-19 in health care workers - A systematic review and meta-analysis. Am J Emerg Med. 2020; 38(9):1727-1731. PMC: 7837172. DOI: 10.1016/j.ajem.2020.05.113. View

Fusco F, Pisaturo M, Iodice V, Bellopede R, Tambaro O, Parrella G . COVID-19 among healthcare workers in a specialist infectious diseases setting in Naples, Southern Italy: results of a cross-sectional surveillance study. J Hosp Infect. 2020; 105(4):596-600. PMC: 7301109. DOI: 10.1016/j.jhin.2020.06.021. View

Au W, Cheung P . Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis. BMJ. 2022; 377:e069989. PMC: 9724446. DOI: 10.1136/bmj-2022-069989. View

Alfaleh A, Alkattan A, Alzaher A, Radwan N, Mahmoud N, Alageel A . Protective Duration of ChAdOx1 and BNT162b2 Vaccines Against SARS-CoV-2 Infection. Clin Drug Investig. 2022; 42(10):799-806. PMC: 9425807. DOI: 10.1007/s40261-022-01195-x. View

Abou-ElWafa H, El-Gilany A, Albadry A . Self-reported COVID-19 among physicians: An Egyptian online study during the pandemic. F1000Res. 2021; 10:785. PMC: 8447048. DOI: 10.12688/f1000research.53931.1. View

Gerhards C, Thiaucourt M, Hetjens M, Haselmann V, Neumaier M, Kittel M . Heterologous Vector-mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector-Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines. Vaccines (Basel). 2023; 11(3). PMC: 10054089. DOI: 10.3390/vaccines11030701. View

Bandyopadhyay S, Baticulon R, Kadhum M, Alser M, Ojuka D, Badereddin Y . Infection and mortality of healthcare workers worldwide from COVID-19: a systematic review. BMJ Glob Health. 2020; 5(12). PMC: 7722361. DOI: 10.1136/bmjgh-2020-003097. View

Lin D, Gu Y, Wheeler B, Young H, Holloway S, Sunny S . Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina. N Engl J Med. 2022; 386(10):933-941. PMC: 8781317. DOI: 10.1056/NEJMoa2117128. View

10.

Mayr F, Talisa V, Shaikh O, Yende S, Butt A . Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans. N Engl J Med. 2022; 386(14):1375-1377. PMC: 8849183. DOI: 10.1056/NEJMc2200415. View

11.

Haas E, Angulo F, McLaughlin J, Anis E, Singer S, Khan F . Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021; 397(10287):1819-1829. PMC: 8099315. DOI: 10.1016/S0140-6736(21)00947-8. View

12.

Ujjan I, Devrajani B, Ghanghro A, Ali Shah S . The clinical and demographical profile of Coronavirus illness: The tale of and in Quarantine / Isolation center at Sukkur and Hyderabad. Pak J Med Sci. 2020; 36(COVID19-S4):S12-S16. PMC: 7306966. DOI: 10.12669/pjms.36.COVID19-S4.2829. View

13.

Yap C, Ali A, Prabhakar A, Prabhakar A, Pal A, Lim Y . Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic. Ther Adv Vaccines Immunother. 2021; 9:25151355211059791. PMC: 8637774. DOI: 10.1177/25151355211059791. View

14.

Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz M . BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med. 2021; 384(15):1412-1423. PMC: 7944975. DOI: 10.1056/NEJMoa2101765. View

15.

Yang J, Parkins M, Canakis A, Aroniadis O, Yadav D, Dixon R . Outcomes of COVID-19 Among Hospitalized Health Care Workers in North America. JAMA Netw Open. 2021; 4(1):e2035699. PMC: 7844592. DOI: 10.1001/jamanetworkopen.2020.35699. View

16.

Amit S, Beni S, Biber A, Grinberg A, Leshem E, Regev-Yochay G . Postvaccination COVID-19 among Healthcare Workers, Israel. Emerg Infect Dis. 2021; 27(4):1220-1222. PMC: 8007324. DOI: 10.3201/eid2704.210016. View

17.

Lai X, Wang M, Qin C, Tan L, Ran L, Chen D . Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China. JAMA Netw Open. 2020; 3(5):e209666. PMC: 7243089. DOI: 10.1001/jamanetworkopen.2020.9666. View

18.

Sharma P, Mishra S, Basu S, Kumar R, Tanwar N . Breakthrough Infection With Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Delhi: A Single-Institution Study. Cureus. 2021; 13(10):e19070. PMC: 8610433. DOI: 10.7759/cureus.19070. View

19.

Chandan S, Khan S, Deliwala S, Mohan B, Ramai D, Chandan O . Postvaccination SARS-CoV-2 infection among healthcare workers: A systematic review and meta-analysis. J Med Virol. 2021; 94(4):1428-1441. PMC: 8661690. DOI: 10.1002/jmv.27457. View

20.

Fiolet T, Kherabi Y, MacDonald C, Ghosn J, Peiffer-Smadja N . Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2021; 28(2):202-221. PMC: 8548286. DOI: 10.1016/j.cmi.2021.10.005. View